24
Oct
2023

Hangzhou Jiuyuan Gene Engineering Co.,Ltd.

Exhibitor at CPHI Barcelona 2023 stand 2W49, Finished Dosage Formulations
About Us

We are a leading biopharmaceutical company firstly developed the following products in China: rhG-CSF (filgrastim),  similar to dalteparin, Enoxaparin sodium, Interleukin-eleven (oprelvekin), Palonosetron Hydrochloride, rhBMP-2 . Liraglutide(recombinant), Fulvestrant,Fosaprepitant dimeglumine.Our product pipeline include: Semaglutide(recombinant),  Semaglutide intermediate (Totally 29 amino acids)，Recombinant HyaluronidasePeg-Filgrastim, Dulaglutide, Ranibizumab, Insulin Detemir, Rivaroxaban, Insulin degludec, Insulin Aspart, Avatrombopag maleate, Daratumumab.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2015
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Barcelona 2023
  • 24-26 October 2023
  • Fira Barcelona Gran Via, Spain
  • Visit us at stand 2W49, Finished Dosage Formulations

Products Featured at CPHI Barcelona 2023

  • Enoxaparin sodium

    Product Enoxaparin sodium

    anticoagulant and antithrombotic, Low Molecular Weight Heparin, Clexane, Lovenox, l  Active pharmaceutical ingredient (API), l  Injection (PFS/ampoule/vial), 0.2ml:2000AxaIU(20mg), 0.4ml:4000AxaIU(40mg), 0.6ml:6000AxaIU(60mg), 0.8ml:8000AxaIU(80mg), 10ml:100,000AxaIU(1g), or other...
  • Filgrastim

    Product Filgrastim

    Filgrastim, Neupogen, G-CSF, Indicated to neutropenia, Formulated bulk liquid, l  Injection (ampoule/PFS/vial) 75µg/unit, 150µg/unit, 300µg/unit, 450µg/unit

  • Fulvestrant

    Product Fulvestrant

    an anti-cancer drug， Bulk and injection (PFS): 250mg in 5ml